614
Views
4
CrossRef citations to date
0
Altmetric
Articles

Effects of iloprost and sildenafil treatment on elabela, apelin-13, nitric oxide, and total antioxidant and total oxidant status in experimental enzyme-positive acute coronary syndrome in rats

, , , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Damu Lin, Hongqiang Wu, Zongwei Zhou, Zhenyu Tao, Tanghong Jia & Weiyang Gao. (2021) Ginkgolide B improves multiterritory perforator flap survival by inhibiting endoplasmic reticulum stress and oxidative stress . Journal of Investigative Surgery 34:6, pages 610-616.
Read now

Articles from other publishers (3)

Maneesha Sharma, Kedar S. Prabhavalkar & Lokesh Kumar Bhatt. (2022) Elabela Peptide: An Emerging Target in Therapeutics. Current Drug Targets 23:14, pages 1304-1318.
Crossref
Meiling Zhou & Yinan Wu. (2022) Effects and signaling pathways of Elabela in the cardiovascular system. Peptides 147, pages 170674.
Crossref
Xiujuan Wang, Guoqing Liang, Qing Guo, Wei Cai, Xin Zhang, Jianmei Ni, Yanyan Tao, Xiulong Niu & Shaobo Chen. (2020) ELABELA improves endothelial cell function via the ELA–APJ axis by activating the PI3K/Akt signalling pathway in HUVECs and EA.hy926 cells . Clinical and Experimental Pharmacology and Physiology 47:12, pages 1953-1964.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.